4.6 Article

Clinical Characteristics Associated with Poor Prognosis of Acquired Immunodeficiency Syndrome Patients Complicated with Disseminated Talaromycosis marneffei

Related references

Note: Only part of the references are listed.
Article Immunology

Evaluation of the yeast phase-specific monoclonal antibody 4D1 and Galanthus nivalis agglutinin sandwich ELISA to detect Talaromyces marneffei antigen in human urine

Fangyi Shu et al.

Summary: This study developed a sandwich ELISA technique for the detection of T. marneffei infection in human urine, and demonstrated its high sensitivity and specificity. The technique could facilitate early diagnosis and monitoring of treatment response in patients with talaromycosis.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2023)

Article Infectious Diseases

HIV-associated talaromycosis: Does timing of antiretroviral therapy matter?

Yuanyuan Qin et al.

Summary: This study aimed to evaluate the optimal timing of antiretroviral therapy (ART) initiation for HIV-positive patients with talaromycosis. The results showed that patients who initiated ART early had lower mortality rates and lower rates of AIDS-defining events or death compared to those who deferred ART initiation.

JOURNAL OF INFECTION (2022)

Article Infectious Diseases

Analysis of clinical characteristics and prognosis of talaromycosis (with or without human immunodeficiency virus) from a non-endemic area: a retrospective study

Qian Shen et al.

Summary: In non-endemic areas, the clinical symptoms, signs, and laboratory tests of patients with talaromycosis are similar to those in endemic areas. Patients with pleural effusion have a lower survival rate, HIV-infected individuals are less likely to relapse, and there is no significant correlation between the extent of lung involvement and the survival of infected patients.

INFECTION (2022)

Article Mycology

Talaromyces marneffei Mp1p Antigen Detection may Play an Important Role in the Early Diagnosis of Talaromycosis in Patients with Acquired Immunodeficiency Syndrome

Chen Xiaoman et al.

Summary: Talaromycosis is a life-threatening fungal disease commonly seen in AIDS patients. The Mp1p enzyme immunoassay can assist in early diagnosis, especially in patients with low CD4+ cell counts.

MYCOPATHOLOGIA (2022)

Article Infectious Diseases

Machine learning-based in-hospital mortality prediction of HIV/AIDS patients with Talaromyces marneffei infection in Guangxi, China

Minjuan Shi et al.

Summary: This study focused on the use of machine learning models to predict the treatment outcomes of HIV/AIDS patients with T. marneffei infection in a hospital in Nanning, Guangxi. The XGBoost model showed the best predictive performance with an AUC of 0.97 in the training dataset and 0.90 in the testing dataset. High CD4/CD8 ratios, AST levels, and other factors were associated with in-hospital mortality in these patients.

PLOS NEGLECTED TROPICAL DISEASES (2022)

Article Medical Laboratory Technology

Clinical features of patients with talaromycosis marneffei and microbiological characteristics of the causative strains

Lei Peng et al.

Summary: This study retrospectively analyzed six cases of T. marneffei infection and confirmed the disease through sputum culture, blood culture, tissue biopsy, and mNGS. The study found that in non-endemic areas, the lack of significant clinical presentations of talaromycosis marneffei can lead to misdiagnosis. Therefore, analyzing the imaging manifestations and laboratory findings is crucial for accurate diagnosis of talaromycosis marneffei.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2022)

Article Infectious Diseases

Talaromyces marneffei is the Persistent Overwhelming Bloodstream Infection Pathogen Among HIV Inpatients in Fujian, China

Jinglan Lai et al.

Summary: This study investigated the epidemiology and etiological spectrums of BSI in HIV/AIDS inpatients in Fujian over the past 6 years. The findings suggest that BSI remains a major issue in hospitalized patients with HIV/AIDS, with Talaromyces marneffei being the predominant pathogen.

INFECTION AND DRUG RESISTANCE (2022)

Article Infectious Diseases

Mortality in hospitalized HIV-infected patients in a referral center in Bahia, Brazil

Luca Nascimento et al.

Summary: The study investigated HIV patients who died in a referral hospital in Salvador, Brazil, and found that the majority of deceased patients were males, blacks, and residents of Salvador with an average age of 41.4 years. Most patients had associated infections and a small percentage had malignant neoplasms. The main reported cause of death was septic shock / HIV-associated infections, with 6.4% of patients having undetectable viral loads.

BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2022)

Article Immunology

Superiority of a Novel Mp1p Antigen Detection Enzyme Immunoassay Compared to Standard BACTEC Blood Culture in the Diagnosis of Talaromycosis

Nguyen T. M. Thu et al.

Summary: The study assessed the accuracy of Mp1p antigen-detecting enzyme immunoassay in diagnosing talaromycosis, showing high specificity and sensitivity compared to blood culture. Additionally, paired plasma and urine testing significantly increased sensitivity, providing a new tool for rapid diagnosis and potentially reducing mortality rates.

CLINICAL INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Prognosis and treatment effects of HIV-associated talaromycosis in a real-world patient cohort

Jonathan Klus et al.

Summary: Talaromycosis is a major cause of AIDS-associated opportunistic infections and death in Southeast Asia, with induction therapy using amphotericin B shown to reduce mortality over 24 weeks. By developing a prognostic model and a causal model, predictors of death can be identified and treatment outcomes can be assessed, providing valuable tools for predicting individual patient outcomes and comparing treatment effects.

MEDICAL MYCOLOGY (2021)

Review Pharmacology & Pharmacy

Antifungal agents and the kidney: pharmacokinetics, clinical nephrotoxicity, and interactions

Athanasios Tragiannidis et al.

Summary: Invasive fungal infections remain a significant concern for severely ill and immunocompromised patients, leading to an increase in research on antifungal drugs. Nephrotoxicity is an important consideration in the use of antifungal agents, particularly for patients with compromised organ functions or receiving other potentially nephrotoxic medications. Amphotericin B deoxycholate is identified as having the highest potential for nephrotoxicity, followed by lipid formulations of amphotericin B and the antifungal triazoles to a much lesser extent.

EXPERT OPINION ON DRUG SAFETY (2021)

Article Infectious Diseases

An inexpensive point-of-care immunochromatographic test for Talaromyces marneffei infection based on the yeast phase specific monoclonal antibody 4D1 and Galanthus nivalis agglutinin

Kritsada Pruksaphon et al.

Summary: A novel immunochromatographic strip test (ICT) was developed for the detection of T. marneffei antigens in clinical urine specimens, showing high sensitivity (89.47%) and specificity (100%) based on validation with 341 urine samples. The ICT provides a rapid and highly accurate diagnostic tool for T. marneffei infection, suitable for clinical application in endemic areas.

PLOS NEGLECTED TROPICAL DISEASES (2021)

Article Oncology

A novel tool for predicting the survival of endoprosthesis used for reconstruction of the knee following tumor resection: a retrospective cohort study

Cheng-Gang Pang et al.

Summary: This study retrospectively reviewed data from 203 patients who underwent knee reconstruction for tumors and identified significant risk factors associated with implant failure. A novel model was established to predict prosthetic survival, showing favorable discrimination ability and accuracy. The length of resection, anatomical location of tumor, and length of prosthetic stem were found to be significantly associated with prosthetic survival.

BMC CANCER (2021)

Article Infectious Diseases

Clinical characteristics and risk factors for poor prognosis among HIV patients with Talaromyces marneffei bloodstream infection

Jianjun Sun et al.

Summary: Talaromyces marneffei bloodstream infection is increasingly common in advanced AIDS patients in endemic areas. Patients with extremely low CD4 and CD8 cell counts below 200/mu l are at increased risk of poor prognosis.

BMC INFECTIOUS DISEASES (2021)

Article Emergency Medicine

Clinical characteristics and risk factors of Talaromyces marneffei infection in human immunodeficiency virus- A observational

Hong-Yan Wei et al.

Summary: The clinical characteristics and risk factors of HIV-negative patients with Talaromyces marneffei infection were investigated. Common manifestations include bone destruction and multiple system damage, with comorbidities like autoimmune diseases playing a role in prognosis. Medication history and immune status may also impact outcomes.

WORLD JOURNAL OF EMERGENCY MEDICINE (2021)

Article Mycology

Voriconazole Versus Amphotericin B as Induction Therapy for Talaromycosis in HIV/AIDS Patients: A Retrospective Study

Weie Huang et al.

Summary: This retrospective study compared the efficacy and safety of voriconazole and dAmB as induction therapy for HIV-associated disseminated talaromycosis. Voriconazole showed similar response rates with shorter durations of induction antifungal therapy and hospital stay, indicating its potential as a better choice in clinical practice. Few adverse reactions occurred in either the voriconazole or dAmB group, suggesting both drugs are safe options for treatment.

MYCOPATHOLOGIA (2021)

Review Infectious Diseases

Diagnostic laboratory immunology for talaromycosis (penicilliosis): review from the bench-top techniques to the point-of-care testing

Kritsada Pruksaphon et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2020)

Article Infectious Diseases

Fatal disseminated Mycobacterium haemophilum infection involving the central nervous system in a renal transplant recipient

Marie Pacholec et al.

JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES (2020)

Review Immunology

Improving survival with tuberculosis & HIV treatment integration: A mini-review

Kogieleum Naidoo et al.

INDIAN JOURNAL OF MEDICAL RESEARCH (2019)